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advantages in reducing the incidence of technical defects
and carotid restenosis.1-4 Although none of these three
methods has been shown to produce clearly superior post-
operative clinical results, carotid patch angioplasty and
eversion CEA have recently received more attention
because of reportedly lower long-term restenosis rates.1-9
In a radical departure from the conventional CEA
method, eversion CEA requires transection of the internal
carotid artery (ICA) at its origin with distal eversion of the
ICA on itself for removal of the plaque.10-12 The need for
transverse sutures on the distal ICA, which may produce
narrowing, is thus avoided because the sutures are placed
longitudinally into the larger junction of the common
carotid artery and proximal ICA. Recent studies indicate
that eversion CEA achieves clinical results comparable to
those of traditional methods, and its more normal postop-
erative hemodynamic characteristics may lower carotid
restenosis rates.13-24 This study was undertaken to com-
pare the technical performance, operative results, and
durability of eversion CEA to those of conventional CEA
with primary arteriotomy closure and prosthetic patch
Over the past 45 years a number of technical innova-
tions have been introduced to improve the clinical results
and long-term durability of carotid endarterectomy
(CEA). In particular, three distinct techniques for per-
forming closure of the CEA arteriotomy have evolved.
These methods include primary arteriotomy closure,
autologous vein or prosthetic carotid patch angioplasty,
and the eversion CEA technique. Carotid patch angio-
plasty is currently preferred over primary arteriotomy clo-
sure by many vascular surgeons because of its theoretical
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Objectives: Despite numerous studies in which various methods for arteriotomy closure after carotid endarterectomy
(CEA) have been addressed, the optimum surgical technique to reduce complications and late carotid restenosis has yet
to be firmly established. The purpose of this study was to prospectively compare the results of the eversion CEA tech-
nique with those of conventional CEA with either primary closure or carotid patch angioplasty, and to determine under
clinical conditions whether eversion CEA influences the results and restenosis rate. 
Patients and Methods: Over a 3-year period, 322 CEAs performed on 296 consecutive patients were concurrently eval-
uated. This study included 118 eversion CEAs, 97 CEAs with primary closure, and 107 CEAs with patch angioplasty.
There were no differences in demographics, in surgical indications, or in the severity of carotid disease (not significant
[NS]). The choice of CEA technique was not randomized because of technical considerations and surgeon preference.
After entry into the protocol, no patients were excluded or withdrawn. Carotid restenosis was defined as a > 60% lumen
reduction at the CEA site with established duplex ultrasonography criteria.
Results: The mean operative time for eversion CEA was 31 minutes, for CEA-primary closure it was 39 minutes, and
for CEA-patch angioplasty it was 46 minutes (P < .01). The operative mortality rate for eversion CEA was 0.8% (1
patient), for CEA-primary closure it was 1.0% (1 patient), and for CEA-patch angioplasty it was 2.8% (3 patients) (NS).
The postoperative stroke rate was 0.8% after eversion CEA, 1.0% after CEA-primary closure, and 2.8% after CEA-patch
angioplasty (NS). The combined stroke and death rate in each group was thus 0.8% for eversion CEA (1 stroke-death),
1% for CEA with primary closure (1 stroke-death), and 5% for CEA with patch angioplasty (1 stroke-death, 2 fatal
myocardial infarctions, and 2 nonfatal strokes) (NS). Transient ischemic attacks occurred in 2.5% after eversion CEA,
in 5.2% after CEA-primary closure, and in 2.9% with CEA-patch angioplasty (NS). The mean clinical follow-up for all
three groups was 23 months (range, 6-42 months) (NS). The restenosis rate was 1.7% after eversion CEA, 9.3% after
CEA-primary closure, and 6.5% after CEA-patch angioplasty (P < .05).
Conclusions: This prospective, nonrandomized clinical study indicates that eversion CEA is an effective surgical option
comparable to conventional CEA with either primary arteriotomy closure or carotid patch angioplasty. No differences
were found between eversion CEA and these more widely accepted CEA closure techniques with respect to operative
morbidity and mortality. These data indicate, however, that eversion CEA has a lower restenosis rate than conventional
CEA closure techniques and thus superior long-term durability. (J Vasc Surg 2001;34:453-8.)
angioplasty under clinical conditions representative of
those found in an established vascular surgery practice
adopting the eversion technique.
PATIENTS AND METHODS
During the 3-year period between July 1997 and July
2000, 322 primary CEAs were performed in 296 consec-
utive patients. All 296 patients were treated by the
Vascular Surgery Service at East Tennessee State
University in two of its affiliated teaching hospitals.
Preoperative assessment of carotid disease included carotid
duplex ultrasonography and confirmation of the severity
of carotid stenosis with contrast angiography or magnetic
resonance angiography. During the study period, no
patients were excluded, withdrawn, or crossed over to
another technique because of clinical circumstances, bilat-
eral carotid disease, the “learning curve,” or intraoperative
technical considerations. Only repeat CEAs performed for
carotid restenosis were excluded.
Patients were entered into this study in a prospective,
but nonrandomized manner. The choice of CEA tech-
nique during each particular operation was based on the
clinical judgment and discretion of the attending vascular
surgeon because of technical concerns or physician prefer-
ence. Technical features generally considered unfavorable
for eversion CEA include anatomically distal ICA stenosis
and bilateral carotid disease increasing the potential need
for shunting; however, with more experience (approxi-
mately 10 cases) these factors were not necessarily found
to be contraindications to eversion CEA. Three operative
techniques were compared in this study: 118 (37%) were
eversion CEAs, 97 (30%) CEAs were closed primarily, and
107 (33%) CEAs were closed with a polyester fiber
(Dacron) or polytetrafluoroethylene (PTFE) patch angio-
plasty. Of these 107 prosthetic patch angioplasties, 103
were collagen coated or impregnated Dacron, and only
four were PTFE. Although operative technique was not
randomized, all three groups were otherwise sufficiently
similar in number and clinical characteristics for valid sta-
tistical comparison. 
Demographic and technical data were collected at the
time of CEA. Postoperative clinical and vascular laboratory
data were entered into a vascular database during the fol-
low-up period. In addition to the evaluation of the techni-
cal aspects of each CEA, primary adverse clinical outcomes
for this study included perioperative death, stroke, tran-
sient ischemic attacks (TIAs), and restenosis at the opera-
tive site. Secondary adverse clinical outcomes were
complications such as nonfatal myocardial infarction,
wound hematoma or bleeding requiring a return to the
operating room, and cranial nerve injury. Patients were fol-
lowed up postoperatively with a serial clinical and vascular
laboratory evaluation. Carotid duplex ultrasonography was
not performed intraoperatively, but was performed in all
surviving patients within 1 to 3 months after CEA to iden-
tify residual atherosclerotic carotid disease. Subsequent
carotid duplex examinations were performed at 12 months
and annually thereafter to evaluate restenosis. Outpatient
carotid duplex examinations were performed in the same
institutions as the operations with standard ultrasonogra-
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Table I. Patient demographics
Demographic
characteristics Eversion CEA CEA primary closure CEA patch angioplasty P value
No. of patients 112 91 93
Mean age (y) 69 70 67 NS
Male sex 109 (92%) 91 (94%) 97 (91%) NS
Smoking 99 (84%) 84 (87%) 89 (83%) NS
Hypertension 82 (73%) 67 (74%) 70 (75%) NS
CAD 38 (34%) 29 (32%) 31 (33%) NS
Diabetes 24 (20%) 16 (16%) 21 (20%) NS
High cholesterol 17 (14%) 14 (14%) 16 (15%) NS
Bilateral CEAs 6 6 14
CAD, Coronary artery disease; CEA, carotid endarterectomy; NS, not significant.
Table II. Indications for surgery
Surgical indication Eversion CEA CEA primary closure CEA patch angioplasty P value
No. of CEAs 118 ( 97 ( 107 (
Symptom free 71 (60%) 62 (64%) 60 (56%) NS
TIA 23 (19%) 17 (18%) 22 (23%) NS
TMB 14 (12%) 8 (8%) 10 (9%) NS
Stroke 10 (9%) 10 (10%) 15 (14%) NS
CEA, Carotid endarterectomy; NS, not significant; TIA, transient ischemic attack; TMB, transient monocular blindness.
phy techniques and criteria. The equipment used was
either an Advanced Technology Laboratories HDI 3000
linear array probe with 7-4 MHz operating frequencies and
a Doppler scan frequency of 4.0 MHz (Bothell, Wash), or
a Hewlett Packard 5500 with 11-4 MHz linear array probe
and a Doppler scan frequency of 3.6 MHz (Andover,
Mass). Carotid restenosis was defined as a postoperative
intraluminal narrowing at or adjacent to the CEA site with
an associated arterial blood flow disturbance indicating a 
>60% stenosis. Hemodynamic criteria consistent with a
>60% restenosis have been validated in these two vascular
laboratories and include an ICA peak systolic velocity more
than 130 cm/s with spectral broadening, an ICA end-
diastolic velocity more than 40 cm/s, or an ICA/common
carotid artery peak systolic velocity ratio more than 1.8.25
Definitions, terminology, and data analysis used in this
study conform to reporting standards for cerebrovascular
disease suggested by the Ad Hoc Committee of the
Society for Vascular Surgery and the North American
Chapter, International Society for Cardiovascular
Surgery.26 All of these patients gave their appropriate
informed consent and were studied under the approval of
the Institutional Review Boards at the James H. Quillen
College of Medicine of East Tennessee State University,
the Mountain Home Veterans Affairs Medical Center, and
the Johnson City Medical Center. Statistical analysis of
these data was performed with χ2 tests of independence
and analysis of variance. Differences were considered to be
statistically significant when P was less than .05.
RESULTS
Patient demographics and indications for CEA were
similar in all three groups, as shown in Tables I and II.
Certain differences, however, were noted between the
three groups with respect to their intraoperative manage-
ment. Nearly all 104 (88%) of eversion CEAs and 74
(69%) of CEAs closed with patch angioplasty were per-
formed with patients under local anesthesia, whereas 52
(54%) of CEAs with primary closure were performed with
patients under general endotracheal anesthesia (P < .01).
Accordingly, carotid shunts were used in 56 (58%) of
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CEAs in the primary closure group, but were required in
only 13 (11%) of eversion CEAs and in 21 (20%) of CEAs
with patch angioplasty (P < .01). The mean operative time
for eversion CEA was 31 minutes, for CEA with primary
closure it was 39 minutes, and for CEA with patch angio-
plasty it was 46 minutes (P < .01).
Primary clinical outcomes for all three groups were
similar, as shown in Table III. The operative mortality rate
within 30 days for eversion CEA was 0.8% (1), for CEA
with primary closure it was 1.0% (1), and for CEA with
patch angioplasty it was 2.8% (3) (not significant [NS]).
Perioperative strokes occurred in one (0.8%) of the ever-
sion CEAs and also in only one (1%) of the CEAs with pri-
mary closure, but occurred in three (2.8%) of CEAs with
patch angioplasty (NS). One stroke-related death
occurred in each group. Two fatal myocardial infarctions
without stroke occurred in the group of patients who
underwent CEA with patch angioplasty. Thus, the overall
combined stroke and death rate indicating total major
morbidity was 0.8% (1 stroke-death) for eversion CEAs,
1% (1 stroke-death) for CEAs with primary closure, and
5% (1 stroke-death, 2 fatal myocardial infarctions without
stroke, and 2 nonfatal strokes) for CEAs with patch angio-
plasty (NS). Postoperative TIAs occurred in three (2.5%)
of eversion CEAs, in five (5.2%) of CEAs with primary clo-
sure, and in three (2.8%) of CEAs closed with patch angio-
plasty (NS). All of these patients fully recovered, and none
have progressed to a permanent neurologic deficit.
Secondary adverse clinical outcomes were also similar in all
three groups, as shown in Table III (NS). No patients
were lost to follow-up, and no late deaths or strokes
occurred during the study period.
The mean clinical follow-up was 23 months (range, 6-
42 months) for all three groups, as shown in Table III
(NS). Serial postoperative carotid duplex examinations
were available in 291 surviving patients. No residual
carotid plaque formation or restenosis at the CEA site was
identified in any of these patients within 3 months post-
operatively. Subsequent carotid restenosis >60% was found
in only 2 (1.7%) eversion CEAs, but occurred in 8 (9.3%)
CEAs with primary arteriotomy closure and in 7 (6.5%)
Table III. Postoperative surgical results and follow-up evaluation
Surgical results Eversion CEA CEA primary closure CEA patch angioplasty P value
No. of CEAs 118 ( 97 ( 107 (
Operative mortality 1 (0.8%) 1 (1%) 3 (2.8%) NS
Strokes 1 (0.8%) 1 (1%) 3 (2.8%) NS
Stroke/deaths 1 (0.8%) 1 (1%) 5 (5%) NS
TIA 3 (2.5%) 5 (5.2%) 3 (2.8%) NS
Nonfatal MI 0 ( 1 (1%) 0 ( NS
Nerve injury 3 (2.5%) 3 (3%) 2 (2%) NS
Postoperative bleeding 3 (2.5%) 1 (1%) 3 (2.8%) NS
Mean follow-up (mo) 23.1 23.8 23.4 NS
>60% restenosis 2 (1.7%) 9 (9.3%) 7 (6.5%) <.05
Repeat CEA 1 (0.8%) 2 (2%) 1 (1%) NS
CEA, Carotid endarterectomy; MI, myocardial infarction; NS, not significant; TIA, transient ischemic attack.
CEAs with prosthetic carotid patch angioplasty (P < .05).
Of these 17 patients with carotid restenosis, none have
required reoperation because of recurrent symptoms.
Four, however, have undergone repeat CEA because of a
critical >90% asymptomatic carotid restenosis confirmed
with angiography: 1 in the eversion CEA group, 2 in the
CEA with primary closure group, and 1 in the CEA patch
angioplasty group (NS).
DISCUSSION
Despite numerous innovations and reports, no CEA
technique has become generally accepted for all patients
and clinical situations. Furthermore, the superiority of one
CEA method over another remains highly controversial
and, thus, the optimal CEA technique to reduce postop-
erative complications and prevent late restenosis remains
unclear. Consequently, as a practical matter, most vascular
surgeons use a number of technical variations for CEA in
their clinical practice and adapt their preference to each
particular situation. As first described by DeBakey et al in
1959, the eversion CEA technique has not been widely
used because of its reputed difficulty and poor visualiza-
tion of the distal ICA plaque end point.10-12 Since the
development of the modified eversion CEA procedure
currently in use, a number of recent studies have demon-
strated the feasibility of eversion CEA and reported clini-
cal results comparable to the more widely used
conventional CEA techniques.5-9,13-23 Despite some
potential advantages, many vascular surgeons remain hesi-
tant, however, to include eversion CEA among their treat-
ment options. The current study was undertaken to
evaluate the results of introducing eversion CEA into a
typical, well-established vascular surgery practice in a prag-
matic manner without limiting the breadth of case selec-
tion or the individual surgeons’ choice of CEA technique.
Thus, in this study, case selection, choice of procedure,
and intraoperative management all reflect the surgeons’
discretion. It can be seen in our data, for example, that
patients under general anesthesia were more likely to be
shunted and that CEA with patch angioplasty technically
required a longer cross-clamp time.
In a number of recent nonrandomized studies, excel-
lent clinical results with eversion CEA compared with con-
ventional CEA are reported. In a retrospective study with
a historical control, Kieny et al5 reported a cumulative
stroke and mortality rate of 2.4% for 212 eversion CEAs
and found >50% restenosis rates during a 4-year follow-up
period of 1.9% after eversion CEA versus 13.5% after CEA
with primary closure. Entz et al18 retrospectively com-
pared eversion CEA with standard CEA with Dacron
patch angioplasty, and reported combined mortality and
morbidity rates of 1.35% versus 4%, respectively. They also
observed a decrease in total operative and carotid cross-
clamp time with the eversion technique. Economopoulos
et al22 retrospectively reviewed 33 eversion CEAs, 15
CEAs with primary closure, and 142 CEAs with patch clo-
sure and reported excellent results overall with only one
stroke and two cardiac deaths in the entire group of 190
patients. A large prospective study by Radak et al23 com-
pared 2124 eversion CEAs with 682 standard CEAs
closed either primarily or with a patch and found mortal-
ity rates from stroke and myocardial infarction of 0.8% and
1.8%, respectively. Overall, the stroke and total morbidity
rates in this study were lower in the eversion CEA group.
Recently, Green et al9 reviewed 107 eversion CEAs com-
pared with 167 CEAs closed with a Dacron patch angio-
plasty and reported one (0.9%) perioperative stroke in the
eversion group versus four (2.4%) strokes in the patch
angioplasty group. Of concern, however, was a >50%
asymptomatic, residual carotid stenosis identified with
duplex ultrasonography in 10% of these cases, 11 after
eversion CEA and 17 after CEA with patch angioplasty.
Interestingly, late carotid restenosis >50% occurred in
4.6% near its proximal suture line after eversion CEA and
in 4.7% distally after CEA with Dacron patch angioplasty.
Comparatively few randomized, prospective trials of
eversion CEA versus conventional CEA are currently avail-
able in the literature. Vanmaele et al13 compared 100 ever-
sion CEAs with 100 conventional CEAs closed with
saphenous vein patch angioplasty and found cumulative
mortality and morbidity rates of 4% and 8%, respectively.
Additionally, they noted a shorter cross-clamp time with
eversion CEA, but more cranial nerve injuries and blood
flow disturbances after CEA with vein patching. Only three
patients had a restenosis of >60% within 9 months: one
after eversion CEA and two after CEA with vein patch
angioplasty. In a somewhat unique study, Ballotta et al21
prospectively evaluated 86 patients who underwent
sequential, bilateral CEAs. Every patient had an eversion
CEA randomly performed on one side and a conventional
CEA closed with a PTFE patch angioplasty on the other;
thus, each case served as its own internal control. There
were no deaths in this study and no strokes related to ever-
sion CEA versus two (3.5%) strokes occurring several hours
after CEA with patch angioplasty. However, the >50%
restenosis rate after 40 months’ mean follow-up was 0% in
the eversion CEA group versus 4.7% in the CEA patch
angioplasty group, with late carotid occlusion rates within
6 months and 1 year of 1.2% versus 7%, respectively.
The most ambitious, randomized, prospective study of
eversion CEA to date is the EVEREST study (EVERsion
carotid Endarterectomy versus Standard Trial), which was
begun in 1994 to compare the efficacy and durability of
eversion CEA versus standard CEA with either primary or
patch angioplasty closure.8,20 In the preliminary published
results from the EVEREST study, Cao et al20 compared
678 patients who underwent eversion CEA with 675
patients who underwent standard CEA and reported peri-
operative major stroke and death rates in both groups of
1.3%. Although carotid cross-clamp time was shorter in
the eversion CEA group, there were no differences with
respect to perioperative TIAs, minor strokes, cranial nerve
injuries, neck hematomas, myocardial infarctions, or surgi-
cal defects. They concluded that eversion was a rapid and
safe operation with low major complication rates and clin-
ical results comparable to standard CEA techniques. The
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subsequent report of these 1353 patients in the EVER-
EST indicates that at a mean follow-up of 33 months,
carotid restenosis > 50% was found in 2.8% after eversion
CEA, in 7.9% after CEA with primary closure, and in 1.5%
after CEA with patch angioplasty.8 The cumulative risk of
carotid restenosis at 4 years was lower in the eversion CEA
group compared with the standard CEA group, 3.6% ver-
sus 9.2%, respectively, with an absolute restenosis risk
reduction of 5.6% and a relative risk reduction of 62%.
Furthermore, multivariate analysis demonstrated that
eversion CEA and CEA with patch angioplasty were both
negative independent predictors of carotid restenosis. The
EVEREST study also found no significant long-term dif-
ferences in the cumulative risk of ipsilateral stroke and
death between eversion and standard CEA.
The above comparisons of eversion and conventional
CEA techniques are generally consistent in their overall
clinical results and restenosis rates and are comparable to
our current study reported here. With respect to major
complications, we found a combined stroke and death rate
of 0.8% for eversion CEA, which was well within the 0% to
4% range reported above. Likewise, our stroke and death
rates of 1% and 5% for CEA with primary closure and CEA
with patch angioplasty, respectively, were also within the
1.3% to 8% range reported for conventional CEA proce-
dures in the above review. Our data were somewhat
skewed by the higher than expected number of nonstroke,
myocardial infarction deaths in the CEA patch angioplasty
group reflecting the higher-risk patients in our veteran
population. The large number of veterans also explains the
relatively few (< 10%) female patients undergoing CEA in
this study, and thus, no conclusions can be drawn as to the
appropriateness of eversion CEA in women who might
have somewhat smaller carotid arteries than men.1
Carotid restenosis is a complex and incompletely
understood postoperative cellular process with probable
biochemical, hemodynamic, and technical aspects.
Unfortunately, there is no generally accepted definition
for a “significant” carotid restenosis, and thus, we used the
> 60% threshold suggested by the Asymptomatic Carotid
Atherosclerotic Study as being more clinically relevant
than the > 50% definition used in several of the above
studies.27 Despite these slight differences in the definition
of restenosis and a number of technical differences with
respect to patch angioplasty (vein versus Dacron versus
PTFE patch materials), the long-term restenosis rates
reported above were similar to those observed in the cur-
rent study. We found a 1.7% restenosis rate with eversion
CEA that was well within the 0% to 4.6% range reported
above. Clearly, CEA with primary closure has the highest
restenosis rate, however measured; we found a 9.3%
restenosis rate in those CEAs closed primarily compared
with 7.9% and 13.5% reported above.7,8 We also found a
6.5% restenosis rate after CEA with patch angioplasty,
which was unexpectedly higher compared with the 1.5% to
4.7% range reported in other studies using a variety of
patch materials. Dacron was used as the patch material in
96% of our 107 CEA patch angioplasties. In contrast, the
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EVEREST used Dacron in 83% of 256 patch angioplasty
procedures with only a 1.5% restenosis rate.8 A number of
differences between the EVEREST protocol and our
study may explain this fourfold difference in restenosis
rates. The EVEREST had a number of clinical exclusions,
and in particular all patients had to be considered candi-
dates for either eversion CEA or the standard operation to
be randomized. Despite this requirement, a number of
EVEREST patients were still withdrawn or crossed over to
another procedure during the study. It is possible that the
EVEREST study patients simply had less extensive carotid
disease, especially in the distal ICA, than would otherwise
be seen in a typical unselected series of patients as repre-
sented by our study. Although the EVEREST randomized
patients between eversion and standard CEA, the choice
of procedure and patch material, if any, within the stan-
dard CEA group was left to the discretion of the vascular
surgeon. In our practice, patients with more extensive dis-
tal carotid disease would most likely be treated by CEA
with patch angioplasty and may be at greater long-term
risk for restenosis. Any of these factors could introduce
bias, ultimately producing the observed variances in
carotid restenosis rates between the two patch angioplasty
groups.
It has been proposed that the configuration of the
carotid artery after eversion CEA may have hemodynamic
advantages compared with other forms of carotid closure.
Baan et al24 evaluated the flow characteristics of normal
carotid arteries compared with CEAs with the eversion
and Dacron patch angioplasty techniques. They concluded
that diameter, strain, and stiffness of the vessel wall after
eversion CEA more closely resembled the nonstenotic,
nonoperated carotid artery than after CEA with Dacron
patch angioplasty. In short, eversion CEA appears to pro-
duce lower carotid restenosis rates than other surgical
options because it minimizes the technical demands of the
carotid arteriotomy closure.6,13
In conclusion, the results from this prospective, non-
randomized study indicate that eversion CEA is an effec-
tive surgical option that should be more frequently
considered by practicing vascular surgeons, especially for
cases involving technical problems related to distal ICA
redundancy and kinking. Eversion CEA is comparable to
conventional CEA with respect to anesthesia management
and use of carotid shunts, and if anything can be per-
formed somewhat more quickly. No differences in opera-
tive morbidity and mortality rates have been found in this
or in earlier studies between eversion CEA and either CEA
with primary closure or CEA with patch angioplasty. More
important, this and other recent studies suggest that ever-
sion CEA may have lower restenosis rates than other CEA
techniques, especially primary carotid arteriotomy closure,
and thus, superior long-term durability. 
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